04 Nov 2025 | 5 Mins Read
Pfizer beats estimates, raises profit outlook despite declining sales
Flipitmoney
Pfizer reported Q3 earnings and revenue above estimates, with EPS at 87 cents vs 63 cents expected and revenue at $16.65 billion vs $16.58 billion. The company hiked full-year profit guidance to $3-$3.15 per share and maintained revenue guidance of $61-$64 billion. Pfizer also disclosed a $1.35 billion charge and planned US manufacturing investment of $70 billion.